Bloomberg Law’s combination of innovative analytics, research tools and practical guidance provides you with everything you need to be a successful litigator.
Johnson & Johnson won dismissal of some 79 suits by non-Missouri residents who sued in Missouri alleging they developed ovarian cancer caused by talcum powder ( Jinright v. Johnson & Johnson, Inc. , 2017 BL 304776, E.D. Mo., No. 17-1849, 8/30/17 ).
The plaintiffs didn’t show a link between their claims and the defendants’ contacts to Missouri, the U.S. District Court for the Eastern District of Missouri said Aug. 30.
Therefore, the court said, it lacked jurisdiction, or authority, over their claims.
The court dismissed the non-residents’ claims without prejudice, and denied the plaintiffs’ motion to send the suit back to the Missouri Circuit Court for St. Louis City, where it had been filed originally.
Talc verdicts from the St. Louis court against J&J have totaled more than $300 million. The company has appealed.
The federal court here applied the U.S. Supreme Court’s June 19 Bristol-Myers Squibb decision, which said a nexus must exist between a plaintiff’s claim and the state where suit is brought.
The plaintiffs argued the matter should be remanded to state court for additional discovery on connections to Missouri that could support jurisdiction there.
They said there is evidence raw talc is sent with a Material Safety Data Sheet warning of the risk of ovarian cancer, to Pharma Tech Industries in Union, Mo.
There, at the direction of Johnson & Johnson, the warning is cast aside and the talc is processed, bottled and labeled without warning, creating the defect in Missouri, the plaintiffs alleged.
But the court said this evidence wouldn’t establish the necessary connection with Missouri.
In Bristol Myers, the Supreme Court said a drugmaker’s contract with a California distributor wasn’t enough to support jurisdiction over nonresidents’ claims.
Similarly, the plaintiffs here have shown only a connection between J&J and a third-party in Missouri, the court said.
Onder & Shelton, LLC represents the plaintiffs.
Hepler Broom represents Johnson & Johnson.
To contact the reporter on this story: Julie A. Steinberg in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Steven Patrick at email@example.com
The opinion is at http://src.bna.com/r8b
Copyright © 2017 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)